Curexo Inc. (KOSDAQ:060280)
15,230
-290 (-1.87%)
Mar 20, 2026, 3:30 PM KST
Curexo Revenue
In the year 2025, Curexo had annual revenue of 74.53B KRW with 34.22% growth. Curexo had revenue of 20.80B in the quarter ending December 31, 2025, with 40.19% growth.
Revenue
74.53B
Revenue Growth
+34.22%
P/S Ratio
22.47
Revenue / Employee
960.27M
Employees
29
Market Cap
625.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.53B | 19.00B | 34.22% |
| Dec 31, 2024 | 55.53B | 28.00B | 101.72% |
| Dec 31, 2015 | 27.53B | 1.39B | 5.33% |
| Dec 31, 2014 | 26.14B | -4.95B | -15.93% |
| Dec 31, 2013 | 31.09B | 6.81B | 28.05% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 458.94B |
| i-SENS | 313.10B |
| InBody Co.,Ltd | 226.62B |
| WON TECH | 147.26B |
| DRTECH | 120.30B |
| Osang Healthcare Co.,Ltd | 119.03B |
| Bio Plus | 96.80B |
| L&C BIO Co.,LTD | 79.99B |